Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Biochemical and Biophysical Research Communications|July 24, 2025
FAXC depletion contributes to tumor progression via the c-MET pathway in renal cell carcinomaMasato Konno, Haruna Fujimori, Shin-Ichiro Kanno, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|November 28, 2023
CD271 promotes proliferation and migration in bladder cancerShingo Myoen, Mai Mochizuki, Rie Shibuya-Takahashi, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|February 19, 2020
Establishment of a Monoclonal Antibody That Recognizes Cysteine-Rich Domain 1 of Human CD271Shinkichi Morita, Mai Mochizuki, Rie Shibuya-Takahashi, et al.
Cancer Science|March 13, 2024
FAXC interacts with ANXA2 and SRC in mitochondria and promotes tumorigenesis in cholangiocarcinomaHaruna Fujimori, Mao Shima-Nakamura, Shin-Ichiro Kanno, et al.
Cancer Science|May 6, 2024
CD271 mRNA/hnRNPA2B1 complex promotes proliferation and stemness in oral and head and neck squamous cell carcinomaMai Mochizuki, Rie Shibuya-Takahashi, Shin-Ichiro Kanno, et al.
Scientific Reports|October 23, 2022
RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancerAkira Nakazato, Mai Mochizuki, Rie Shibuya-Takahashi, et al.
Cancer Science|August 23, 2021
BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinomaDaisuke Fukushi, Rie Shibuya-Takahashi, Mai Mochizuki, et al.
Biochemical and Biophysical Research Communications|March 18, 2023
BEX2 is poor prognostic factor and required for cancer stemness in gastric cancerAkihiro Yasumoto, Haruna Fujimori, Mai Mochizuki, et al.
Scientific Reports|December 10, 2020
BEX2 suppresses mitochondrial activity and is required for dormant cancer stem cell maintenance in intrahepatic cholangiocarcinomaKeiichi Tamai, Mao Nakamura-Shima, Rie Shibuya-Takahashi, et al.
Pageof 2